Onconetix Inc (ONCO) Stock Price, Quote & News

Company Profile

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the Panc...

Industry: Biotechnology

Sector: Healthcare

Phone: 513 620 4101

Website: www.onconetix.com

Address:

201 East Fifth Street, Suite 1900, Cincinnati, United States

SniperMaster00 Apr. 3 at 7:57 PM

$ONCO let’s see a $ELAB move next week!

0 · Reply

BearTamerTrading Apr. 3 at 6:25 PM

🚨 $ONCO — SQUEEZE SETUP OR TRAP? READ THIS ⚠️ This one has attention… but let’s break it down the RIGHT way. ⸻ 📊 Squeeze Metrics: 🔥 CTB: 500%+ 📈 SI: 50–100%+ ⚠️ Utilization: ~84% ❌ DTC: 0.26 (low = can cover fast) 👉 Pressure is there… but not trapped yet ⸻ 💣 DILUTION CHECK: • Multiple S-1 + 424B3 filings 👉 Shares registered for resale 👉 Can sell into ANY strength ⸻ 📉 Chart: • Downtrend still intact • Pops getting sold ⸻ 🚀 What we NEED: 1. Catalyst 📰 (AI/news helps) 2. Volume surge 🔥 3. Break $1.65–$1.75 ⸻ 🔥 Squeeze trigger: 👉 Over $1.90–$2.00 ⸻ 🔴 Risk: Below $1.30 = weak ⸻ 💰 Game Plan: Quick trades only — no holding “Low DTC + dilution = no fear yet” Stay sharp 👀

0 · Reply

sam32 Apr. 3 at 4:03 PM

$ONCO Let’s see $2+ next week

0 · Reply

Melting_Candlestix Apr. 3 at 12:29 PM

$DEFT $ONCO $PFSA $SKYQ $VSA

0 · Reply

SvenneKaare Apr. 3 at 5:45 AM

$ONCO once again a Friday AH sell off…and just like last week, we’ll open strong on Monday🥳🚀 Completely oversold🚀

1 · Reply

seriousrookie Apr. 2 at 11:41 PM

$ONCO Wow! Nice low volatility base formed this week. It has the potential to pop.

0 · Reply

Trader_Vo Apr. 2 at 11:33 PM

$DEFT $ONCO $PFSA $SKYQ $VSA

1 · Reply

TeamBullish Apr. 2 at 11:33 PM

Be sure to sub on YouTube! Will have a video posted this weekend for top watches into the next week. $ONCO $VSA $PFSA $SKYQ $DEFT. What are your top watches? 👀 https://youtube.com/@teambullishtrading?si=WNSEuA0jweHBtfFi

2 · Reply

SniperMaster00 Apr. 2 at 9:59 PM

$ONCO 👀 on this play! I’m in at $1.48 easy $2+ soon! Let the rookies sell

0 · Reply

Acan1219 Apr. 2 at 8:07 PM

$ONCO And that’s when the Dilution starts! They have no money what do you think is going to happen?? Dump shares then R/S I sold my 25,000 shares PM Made some bank 🏦 The Proxy tells the tale!

1 · Reply

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

Mar 31, 2026, 8:30 AM EDT - 5 days ago

Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

Mar 25, 2026, 12:47 PM EDT - 10 days ago

Onconetix Highlights Realbotix's Role in Ericsson's World-First 6G Trial Demonstration

Mar 23, 2026, 8:30 AM EDT - 13 days ago

Onconetix, Inc. Announces 1-for-5 Reverse Stock Split

Feb 12, 2026, 8:00 AM EST - 7 weeks ago

Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company

Feb 12, 2026, 8:00 AM EST - 7 weeks ago

Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer

Sep 26, 2025, 8:30 AM EDT - 6 months ago

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

Sep 26, 2025, 8:15 AM EDT - 6 months ago

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

Sep 22, 2025, 8:00 AM EDT - 6 months ago

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

Jul 16, 2025, 8:17 AM EDT - 9 months ago

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

Jun 16, 2025, 8:22 AM EDT - 10 months ago

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

Jun 11, 2025, 11:30 AM EDT - 10 months ago

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

May 22, 2025, 4:50 PM EDT - 11 months ago

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

May 22, 2025, 10:00 AM EDT - 11 months ago

Onco-Innovations Uplists to Cboe Canada

Mar 24, 2025, 8:45 AM EDT - 1 year ago

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

Dec 12, 2024, 5:00 PM EST - 1 year ago

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

Oct 8, 2024, 5:00 AM EDT - 1 year ago

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

OCS VRNA GRDX

Oct 3, 2024, 4:45 PM EDT - 1 year ago

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Oct 3, 2024, 9:05 AM EDT - 1 year ago

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Sep 27, 2024, 2:41 PM EDT - 1 year ago

Crude Oil Rises; Onconetix Shares Spike Higher

Sep 20, 2024, 11:45 AM EDT - 1 year ago

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

Jul 15, 2024, 6:00 AM EDT - 1 year ago

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

Jul 11, 2024, 8:17 AM EDT - 1 year ago

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

Feb 13, 2024, 6:00 AM EST - 2 years ago

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

Dec 19, 2023, 7:00 AM EST - 2 years ago

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

Dec 18, 2023, 7:00 AM EST - 2 years ago

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Nov 2, 2023, 7:00 AM EDT - 2 years ago

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

Nov 1, 2023, 7:00 AM EDT - 2 years ago

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

Oct 30, 2023, 7:00 AM EDT - 2 years ago

Blue Water Biotech Issues Letter to Shareholders

Oct 10, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO

Aug 28, 2023, 4:30 PM EDT - 2 years ago

Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Aug 3, 2023, 1:02 PM EDT - 2 years ago

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Aug 1, 2023, 8:00 AM EDT - 2 years ago

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Jul 31, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

Jul 25, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

Jul 17, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

Jul 11, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support

Jul 6, 2023, 5:05 PM EDT - 2 years ago

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

Jul 6, 2023, 7:30 AM EDT - 2 years ago

Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio

Jun 28, 2023, 7:55 AM EDT - 3 years ago

Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

Jun 21, 2023, 7:30 AM EDT - 3 years ago

Blue Water Biotech Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product Portfolio

Jun 14, 2023, 7:30 AM EDT - 3 years ago

Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment Areas

May 12, 2023, 6:32 PM EDT - 3 years ago

Blue Water Biotech Reports First Quarter 2023 Financial Results and Recent Business Highlights

May 10, 2023, 12:15 PM EDT - 3 years ago

Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY

Apr 26, 2023, 3:44 PM EDT - 3 years ago

Blue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical Officer

Apr 25, 2023, 8:00 AM EDT - 3 years ago

Blue Water Biotech to Participate in the American Urological Association Annual Meeting 2023 to Promote Benign Prostatic Hyperplasia Treatment ENTADFI®

Apr 24, 2023, 8:00 AM EDT - 3 years ago

Blue Water Vaccines Announces Corporate Name Change to Blue Water Biotech in Connection with Transition into Commercial-Stage Biotechnology Company

Apr 20, 2023, 7:30 AM EDT - 3 years ago

Blue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign Prostatic Hyperplasia Asset

SniperMaster00 Apr. 3 at 7:57 PM

$ONCO let’s see a $ELAB move next week!

0 · Reply

BearTamerTrading Apr. 3 at 6:25 PM

0 · Reply

sam32 Apr. 3 at 4:03 PM

$ONCO Let’s see $2+ next week

0 · Reply

Melting_Candlestix Apr. 3 at 12:29 PM

$DEFT $ONCO $PFSA $SKYQ $VSA

0 · Reply

SvenneKaare Apr. 3 at 5:45 AM

$ONCO once again a Friday AH sell off…and just like last week, we’ll open strong on Monday🥳🚀 Completely oversold🚀

1 · Reply

seriousrookie Apr. 2 at 11:41 PM

$ONCO Wow! Nice low volatility base formed this week. It has the potential to pop.

0 · Reply

Trader_Vo Apr. 2 at 11:33 PM

$DEFT $ONCO $PFSA $SKYQ $VSA

1 · Reply

TeamBullish Apr. 2 at 11:33 PM

2 · Reply

SniperMaster00 Apr. 2 at 9:59 PM

$ONCO 👀 on this play! I’m in at $1.48 easy $2+ soon! Let the rookies sell

0 · Reply

Acan1219 Apr. 2 at 8:07 PM

$ONCO And that’s when the Dilution starts! They have no money what do you think is going to happen?? Dump shares then R/S I sold my 25,000 shares PM Made some bank 🏦 The Proxy tells the tale!

1 · Reply

focafoca99 Apr. 2 at 7:52 PM

$ONCO is highlighting Realbotix's delivery update ahead of the pending acquisition, saying 19 robots are expected to ship across March, April and May as production scales.

0 · Reply

JackSch Apr. 2 at 7:13 PM

$ONCO the only mother fucking time I held. Look what happened!

0 · Reply

Mg_1970 Apr. 2 at 6:42 PM

$ONCO $NPT 😎😎😍😍😍💪

0 · Reply

GTMStox Apr. 2 at 6:40 PM

$ONCO If you're looking for trash you've come to the right place.

0 · Reply

TATTED_KEN Apr. 2 at 5:27 PM

$ONCO rinse and repeat till we hit $5+

1 · Reply

Mg_1970 Apr. 2 at 5:09 PM

$ONCO 😱😱😱😂 Onestly with my method I gained a lot...read my previous posts...😎😎👊 There are no volumes today

0 · Reply

Virealize340 Apr. 2 at 4:57 PM

$ONCO you keep selling I will keep loading

0 · Reply

PLATINUM_TRADES Apr. 2 at 4:53 PM

$ONCO Adds! Let the newbies get nervous... The fake pumpers are gone and left their newbie followers holding the bag with their loss. They deserve it... Now I'll take it 😁😁

0 · Reply

GTMStox Apr. 2 at 4:49 PM

$ONCO So glad I sold this trash on that pop yesterday

0 · Reply

KuruHabesha Apr. 2 at 4:49 PM

$ONCO Adding

0 · Reply

ka1954 Apr. 2 at 4:48 PM

$ONCO dont apply analysis to junk stock. they never do anything the way it shud happen

0 · Reply

ka1954 Apr. 2 at 4:47 PM

$ONCO lol. this stock is the ultimate joke !!!

0 · Reply

Market Cap	997,000.00
Revenue (ttm)	820,000.00
Net Income (ttm)	-14.03M
EPS (ttm)	N/A
PE Ratio	0.02
Forward PE	N/A
Profit Margin	-1,710.98%
Debt to Equity Ratio	0.00

Volume	966,400
Avg Vol	1,631,648
Day's Range	N/A - N/A
Shares Out	656,000.00
Stochastic %K	6%
Beta	3.63
Analysts	Strong Buy
Price Target	N/A